ApprovalTrail

Approval · Notice of Compliance 5262 · 1995

SYN-TICLOPIDINE: Notice of Compliance 5262

Issued November 17, 1995

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
5262
Date
November 17, 1995
Company
Syncare Pharmaceutical Inc.Mississauga, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Admin
Therapeutic class
Inhibitor of platelet function

Products in this notice

BrandDINStatus today
SYN-TICLOPIDINE02194422Cancelled Post Market

Medicinal ingredients